Innocan signs deal with Hebrew university while also signing distribution deal

viewInnoCan Pharma

Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive Vancouver from Toronto with news the company has signed a deal with the distribution company Active Therapeutics. This agreement allows Innocan to move into the U.K. and Ireland. 

Bincovich also told Proactive about the work they will be doing with Hebrew University and also about a new board member who comes with a very big resume.


Market: CSE
Market Cap: $14.39 m

View company profile

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of InnoCan Pharma named herein, including the promotion by the Company of InnoCan Pharma in any Content on the Site, the Company receives from...


Most read

InnoCan Pharma looking at their CBD by injection technology as a game changer

InnoCan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive in Toronto to talk about the CBDcompnay and some of their interesting technology including the development of CBD by Injection. Bincovich also told Proactive about their topical vertical that will focus on pain...

on 11/04/2019

2 min read

Buds & Duds: Marijuana stocks jump as US markets g...
Medlab launches NanaBis™ study into cancer pain ma...